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Abstract
Background: Uterine or endocervical biopsies that contain endometrioid adenocarcinoma with
widespread squamous metaplasia are usually of endometrial origin. The presence of squamous
metaplasia is said to be helpful in distinguishing endocervical from endometrial adenocarcinomas in
small biopsy samples.
Case presentation: A 51-year-old woman presented with post-coital and post-menopausal
bleeding. Biopsy of a friable lesion in the proximal endocervical canal revealed an endocervical
adenocarcinoma of endometrioid type with widespread squamous metaplasia. The latter feature
initially raised the possible diagnosis of a primary endometrial adenocarcinoma. However,
immunohistochemical marker studies indicated a diagnosis of primary endocervical
adenocarcinoma of endometrioid type and this was confirmed at hysterectomy.
Conclusion: Squamous differentiation is not well documented in endocervical adenocarcinomas
of endometrioid type and, when widespread, may represent a diagnostic pitfall for pathologists.
Interpretation of small biopsies from the endocervical canal on the basis of morphology alone may
lead to misdiagnosis and inappropriate surgical management.
Background
Differentiating between endocervical and endometrial
adenocarcinoma in small pre-operative endocervical and
endometrial specimens may be difficult: endometrial ade-
nocarcinomas may involve the endocervix and endocervi-
cal neoplasms may be sampled en-route to the
endometrial cavity, and primary tumours at both of these
sites may show histological similarities. Endometrioid
adenocarcinomas are a recognised subtype of tumours of
the cervix [1] and mucinous differentiation may be seen in
both endocervical and endometrial adenocarcinomas; the
presence of mucin is not therefore a discriminating fea-
ture. In contrast, squamous differentiation is a well-recog-
nised feature of endometrial but not endocervical
adenocarcinomas. In his review of the pathology of
endocervical glandular lesions, McCluggage states that
one of the clues to a primary endometrial lesion is the
presence of benign squamous cells [2].
We describe a patient from whom friable tissue removed
from the endocervical canal showed adenocarcinoma
with an endometrioid morphology, focal mucinous dif-
ferentiation and widespread benign squamous (morular)
metaplasia suggestive of a primary endometrial adenocar-
cinoma but who was subsequently found to have a pri-
mary endocervical adenocarcinoma of predominantly
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endometrioid type. Squamous differentiation in primary
endocervical adenocarcinomas of endometrioid type is
poorly documented but can be a prominent feature.
Case presentation
A 51-year-old woman presented with post-coital and post-
menopausal bleeding. Gynaecological examination
revealed a friable lesion in the endocervical canal. Clini-
cally a diagnosis of an endocervical neoplasm was raised.
The lesion was biopsied and two friable, haemorrhagic tis-
sue fragments up to 10 mm in diameter were submitted
for histology.
Results
Histology revealed adenocarcinoma of endometrioid type
with a complex tubulopapillary and cribriform architec-
ture. The tumour showed focal mucinous and more wide-
spread benign squamous differentiation (morular
metaplasia) (Fig. 1a, b). The combined FIGO grade was I.
Alcian blue- and PAS-positive cytoplasmic mucin was
present in the mucinous but not the endometrioid areas
(Fig. 1c). The biopsy did not include any normal endocer-
vical or endometrial tissue, any endocervical fragments
with CGIN, or hyperplastic endometrial tissue. Since
endometrioid endometrial adenocarcinomas may show
mucinous differentiation and squamous metaplasia, the
possibility of a primary endometrial adenocarcinoma was
considered on the basis of the histology. However, as an
endocervical neoplasm had been considered clinically,
immunohistochemical marker studies were performed to
exclude the possibility of a primary endocervical neo-
plasm.
Sections were immunostained using a standard strepavi-
din-biotin technique, with antibodies to carcinoembry-
onic antigen (CEA; polyclonal, Dako, Ely, UK, 1:10,000
dilution), p16 (Novocastra, Newcastle-upon-Tyne,
1:100), oestrogen receptor (Vector Laboratories, Peterbor-
ough, UK 1:100) and vimentin (Dako, UK, 1:600). Both
the squamous morules and the mucinous areas marked
strongly for CEA. There was much less labelling of the
endometrioid areas, within which staining was largely
confined to the luminal surface of some of the glands.
Only very focal cytoplasmic staining was observed for
vimentin, approximately 10% of the tumour cell nuclei
were weakly immunopositive for oestrogen receptor, and
there was strong cytoplasmic and nuclear labelling of
both the squamous and glandular elements for p16.
Despite the histological features that had suggested pri-
mary endometrial adenocarcinoma (with mucinous dif-
ferentiation and widespread squamous metaplasia), the
immunohistochemical profile favoured a primary
endocervical neoplasm.
Radiological investigations indicated that the carcinoma
was located high in the endocervix and a radical hysterec-
tomy was performed. The resected specimen was received
at a nearby hospital and not photographed. However, it
(A) and (B) Endometrioid adenocarcinoma with a cribriform  glandular architecture Figure 1
(A) and (B) Endometrioid adenocarcinoma with a cribriform 
glandular architecture. Foci of benign squamous (morular) 
metaplasia (arrows) are present between glandular struc-
tures. Haematoxylin and eosin; objective magnification ×20 
(A), ×40 (B). (C) Alcian blue and PAS-positive cytoplasmic 
mucin (arrows) in the mucinous but not the endometrioid 
glands. Objective magnification ×40.Diagnostic Pathology 2007, 2:40 http://www.diagnosticpathology.org/content/2/1/40
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was extensively sampled for histology. All of the sections
were reviewed by the first two authors and a diagnosis of
a FIGO stage IB1, grade I adenocarcinoma of mixed
endometrioid and mucinous subtype was identified on
the posterior cervical lip, with associated lymphovascular
invasion. Multiple foci of squamous metaplasia were
present in the adenocarcinoma in the areas with an
endometrioid morphology. The histological appearances
were identical to those in the original biopsy. There was
no adjacent CGIN or CIN in the cervix, and no evidence
of a primary endometrial neoplasm. The paracervical and
parametrial tissues and all of the resected pelvic lymph
nodes were tumour-free.
Discussion
The distinction between primary endometrial and
endocervical adenocarcinomas is important for optimal
patient management. Localized endocervical adenocarci-
noma is best treated by chemoradiation or radical hyster-
ectomy and pelvic lymphadenectomy. The treatment of
endometrial adenocarcinoma depends on the stage of dis-
ease and may not involve such extensive surgery. It can be
difficult to differentiate between primary endometrial and
endocervical adenocarcinomas in small endometrial or
endocervical samples. Squamous differentiation, most
commonly in the form of benign squamous metaplasia, is
a well-recognised feature of endometrial adenocarcino-
mas of both primary endometrial and ovarian origin. The
present case illustrates that widespread squamous differ-
entiation may also occur in primary endometrioid adeno-
carcinoma of the cervix.
Endometrioid adenocarcinomas of the cervix are a sub-
type of primary endocervical adenocarcinoma [1].
Although Young and Clement [1] regard this subtype of
endocervical adenocarcinoma to be uncommon, others
have reported it to account for up to 30% of primary
endocervical adenocarcinomas [3]. Alfsen et al [4]
reported an increase in the proportion of non-squamous
carcinomas of the cervix over the past few decades in Nor-
way, endometrioid adenocarcinoma accounting for 21%.
Endometrioid endometrial adenocarcinomas can show
both squamous and mucinous differentiation. Zaino [5]
reported squamous differentiation in up to 25% of
endometrioid adenocarcinomas but others [3] describe
this in 20–50% or more. Mucinous differentiation is also
described in primary endometrial adenocarcinomas [6-8].
Because of the endometrioid morphology and squamous
and mucinous differentiation, the histology of the
endocervical biopsy was thought initially to favour pri-
mary endometrial adenocarcinoma.
The immunohistochemical differentiation of endocervi-
cal from endometrial adenocarcinoma has been described
in several publications [2,9-11] and a limited marker
panel has been recommended. More extensive immuno-
histochemical investigations are occasionally warranted
for rarer endometrial and cervical tumours [12,13]. In the
present case, despite the morphology, immunohisto-
chemical marker studies favoured a diagnosis of primary
endocervical adenocarcinoma – a diagnosis confirmed at
hysterectomy. This case emphasizes the value of immuno-
histochemical marker studies, particularly when the clini-
cal details and histological findings seem discordant;
endometrioid endocervical adenocarcinoma should be
considered even in the presence of squamous metaplasia.
Squamous metaplasia may be a prominent feature of
endometrioid tumours, whatever their primary anatomi-
cal site of origin.
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